Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery

Authors: Xiaobin Chen, Maoli Wang, Xiaowei Yang, Yaoben Wang, Lin Yu, Jian Sun, Jiandong Ding - Theranostics 2019 cited by 122

: The Herceptin-loaded hydrogel has great potential for preventing the relapse of HER2+ breast tumors after breast-conserving surgery with enhanced therapeutic efficacy, improved patient compliance and significantly reduced side effects.